All issues > Volume 1(3); 1958
- Original Article
- J Korean Pediatr Soc. 1958;1(3):25-34. Published online March 31, 1958.
- 韓國兒童의 류마치스熱에 對하여
- Chong M Park1, Kun W Chang1, Chang W Song1
- 1Department of Pediatrics, Presbyterian Hospital Taegu, Korea
- Abstract
- Two hundred and fifteen Rheumatic Fever cases in the Children’s Hospital and Presbyterian Hosptal in Taegu, Korea, during the past three years and four months period (Jan. 1955-April 1958) have been reviewed.
The incidence, per annum, during the past two years period(1955一1957) ranged, from about 2.3 to 2.7 per 1,000 children in our hospital. From a school survey(three kindergartens and three elementary schools) we found that rheumatic heart disease has detected among school children at a rate of from 0.35 to 1.5 per cent.
The following features are discussed:definition, epidemiology, (incidence, seasonal incidence, age distribution, sex incidence, heredity, economic social factor, relationship between rheumatic fever and other streptococcal infections) clinical syndrome, diagnosis and treatment. 1.The average incidence, per annum, was 1.5% in the hospital and 79% of rheumatic fever cases had organic rheumatic heart disease. 2.The highest seasonal incidence was in the Springfpeak in April). The winter-season was next. 3.The highest age incidence in children occured between the ages of 5 to 8(peak in July), which accounted for about 47% of total rheumatic fever patients. 4.Male children were predominant in sex incidence at the rate of 5:3. This is probably to some extent due to the oriental custum of putting importance on. male, rather than female children. 5. Major clinical manifestations were as follows a.Carditis79% (of cases) b. Migratory polyarthritis35% c.Chorea 3% d.Erythema marginatum & annulare 13% e. Subcutaneous nodule 1% f. History of reccurent attaks 37% 6. The incidence of rheumatic fever was closely related to the other streptococcal infections such as acute tonsillitis, scarlet fever and erysipelas. 7. Continuous administration of oral penicillin (250,000 U. /d) or sulfadiazine (0.25—0.5 gm/d) for prophylactic use against reccureat attacks was found quite satisfactory (94%).
Keywords :